rafivirumab
rafivirumab Basic information
- Product Name:
- rafivirumab
- Synonyms:
-
- rafivirumab
- Research Grade Rafivirumab(DVV03902)
- Research Grade Rafivirumab
- Rafivirumab (anti-Rabies virus GP)
- CAS:
- 944548-37-2
- MW:
- 0
- Mol File:
- Mol File
rafivirumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
rafivirumab Usage And Synthesis
Uses
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab can be used for research of cocktails[1][2][3].
in vivo
Rafivirumab (3-12 μg/kg,i.m.) together with CR4098 increases survival in syrian hamsters infected with bat rabies viruses[2].
| Animal Model: | Syrian hamsters infected with bat rabies viruses[2]. |
| Dosage: | 6, 12, 16, 18 or 24 μg/kg of CL184 (mixture of Rafivirumab and CR4098 in 1:1 protein ratio) |
| Administration: | i.m. |
| Result: | Increased survival rate. |
References
[1] Kramer RA, et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol. 2005 Jul;35(7):2131-45. DOI:10.1002/eji.200526134
[2] Franka R, et al. In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants. Trop Med Infect Dis. 2017 Sep 20;2(3):48. DOI:10.3390/tropicalmed2030048
[3] Ejemel M, et al. A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Sci Rep. 2022 Jun 7;12(1):9403. DOI:10.1038/s41598-022-13527-0
rafivirumabSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15817493340
- 981810490@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 4008200310
- marketing@tsbiochem.com